Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.

[1]  Shuang Huang,et al.  KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism. , 2016, Cell reports.

[2]  K. Vousden,et al.  Serine Metabolism Supports the Methionine Cycle and DNA/RNA Methylation through De Novo ATP Synthesis in Cancer Cells , 2016, Molecular cell.

[3]  S. Shieh,et al.  Requirement for human Mps1/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation , 2015, Nucleic acids research.

[4]  R. Deberardinis,et al.  NRF2 regulates serine biosynthesis in non-small cell lung cancer , 2015, Nature Genetics.

[5]  M. V. Vander Heiden,et al.  Lack of Evidence for PKM2 Protein Kinase Activity. , 2015, Molecular cell.

[6]  M. V. Heiden,et al.  Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells , 2015, Cell.

[7]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[8]  R. Deberardinis,et al.  Metabolic pathways promoting cancer cell survival and growth , 2015, Nature Cell Biology.

[9]  C. Su,et al.  Identifying the determinants of response to MDM2 inhibition , 2015, Oncotarget.

[10]  Wenwei Hu,et al.  Tumor suppressor p53 and its mutants in cancer metabolism. , 2015, Cancer letters.

[11]  W. Gu,et al.  p53 Protein-mediated Regulation of Phosphoglycerate Dehydrogenase (PHGDH) Is Crucial for the Apoptotic Response upon Serine Starvation* , 2014, The Journal of Biological Chemistry.

[12]  M. Morello,et al.  Bioinformatics analysis of the serine and glycine pathway in cancer cells , 2014, Oncotarget.

[13]  Jiandong Chen,et al.  Autoactivation of the MDM2 E3 Ligase by Intramolecular Interaction , 2014, Molecular and Cellular Biology.

[14]  D. Lane,et al.  Drugging the p53 pathway: understanding the route to clinical efficacy , 2014, Nature Reviews Drug Discovery.

[15]  D. Lane,et al.  Drugging the p53 pathway: understanding the route to clinical efficacy , 2014, Nature Reviews Drug Discovery.

[16]  J. Manfredi,et al.  p53-independent effects of Mdm2. , 2014, Sub-cellular biochemistry.

[17]  Yunhong Zha,et al.  The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation. , 2013, Cell metabolism.

[18]  K. Vousden,et al.  Metabolic Regulation by p53 Family Members , 2013, Cell metabolism.

[19]  J. Locasale.  Serine, glycine and one-carbon units: cancer metabolism in full circle , 2013, Nature Reviews Cancer.

[20]  G. Wahl,et al.  MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.

[21]  Karen Blyth,et al.  Serine starvation induces stress and p53 dependent metabolic remodeling in cancer cells , 2012, Nature.

[22]  Guillermina Lozano,et al.  Molecular Pathways: Targeting Mdm2 and Mdm4 in Cancer Therapy , 2012, Clinical Cancer Research.

[23]  V. Rotter,et al.  Regulation of lipid metabolism by p53 – fighting two villains with one sword , 2012, Trends in Endocrinology & Metabolism.

[24]  Eyal Gottlieb,et al.  Serine is a natural ligand and allosteric activator of pyruvate kinase M2 , 2012, Nature.

[25]  Wei Gu,et al.  Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.

[26]  V. Mootha,et al.  Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.

[27]  J. Rabinowitz,et al.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation , 2012, Proceedings of the National Academy of Sciences.

[28]  C. Prives,et al.  Mdm2 and MdmX as Regulators of Gene Expression. , 2012, Genes & cancer.

[29]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[30]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[31]  이연수.  Functional genomics reveal that the serine synthesis pathway is essential in breast cancer , 2011 .

[32]  Hua Lu,et al.  MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3* , 2010, The Journal of Biological Chemistry.

[33]  J. Marine,et al.  Mdm2-mediated ubiquitylation: p53 and beyond , 2010, Cell Death and Differentiation.

[34]  B. K. Park,et al.  MDM2 regulates dihydrofolate reductase activity through monoubiquitination. , 2008, Cancer research.

[35]  G. Wahl,et al.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.

[36]  Tsonwin Hai,et al.  Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination , 2005, The EMBO journal.

[37]  L. Mayo,et al.  A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Patrick T. Reilly,et al.  Loss of HCF-1–Chromatin Association Precedes Temperature-Induced Growth Arrest of tsBN67 Cells , 2001, Molecular and Cellular Biology.

[39]  L. Donehower,et al.  Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Levine,et al.  Differential Regulation of the p21/WAF-1 and mdm2 Genes after High-Dose UV Irradiation: p53-Dependent and p53-Independent Regulation of the mdm2 Gene , 1997, Molecular medicine.

[41]  Lawrence A. Donehower,et al.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.

[42]  Guillermina Lozano,et al.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.

[43]  T. Kinoshita,et al.  The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. , 1994, Blood.

[44]  A. Levine,et al.  Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. , 1994, Cancer research.

[45]  M. Oren,et al.  mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.

[46]  A. Halestrap.  The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. , 1975, The Biochemical journal.